US 12048692
Methods for treating chronic obstructive pulmonary disease
granted A61KA61K31/135A61K31/444
Quick answer
US patent 12048692 (Methods for treating chronic obstructive pulmonary disease) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/135, A61K31/444, A61K31/4545, A61K31/5386